A 1970s Lipid-Lowering Compound May Offer a New Approach to Obesity
Obesity can cause metabolic conditions, including abnormal blood lipid levels, insulin resistance, and diabetes. Incretin-based drugs, such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), continue to see widespread use for...
Read More
Patients with IBD Show Higher Risk of Psychiatric Disorders
By Irene Yeh September 11, 2026 | Evidence suggests that patients with inflammatory bowel disease (IBD), comprising Crohn’s disease (CD), ulcerative colitis (UC), and IBD-unclassified (IBD-U), may be more susceptible...
Read More
LinusBio’s Traced Uses Hair to Build a Molecular Record of Environmental Exposures
By Allison Proffitt September 8, 2026 | LinusBio is delving into the exposome with Traced, a new hair testing tool designed to give consumers a month-long view of their exposure...
Read More
Food as Medicine 2026: The Best and Worst of Times
By Irene Yeh May 8, 2026 | During the opening keynote panel at this week’s Food as Medicine Summit in Chicago, Rick Leach, executive director of the Food as Medicine Initiative at Arizona State...
Read More
Review Paper Links Brain-Gut-Sleep Development in First 1,000 Days
By Allison Proffitt May 7, 2026 | A new paper published in Nutrients outlines the connected development of the brain, gut, and sleep in the first 1,000 days of life—from...
Read More
Adolescent Sleep as a Biomarker for Cardiovascular Health in Young Adulthood
By Allison Proffitt October 29, 2025 | We know that sleep predicts cardiovascular health for middle-aged and older adults. But are sleep patterns as adolescents a biomarker for cardiovascular health...
Read More